Remove solutions
article thumbnail

9 Ways Worldwide Optimizes Clinical Development for Your Biotech Growth Journey

Worldwide Clinical Trials

Selecting the right CRO to partner with on your development program is a pivotal decision that can shape the trajectory of your product’s development. Our consultative approach ensures success by integrating research methodology, regulatory affairs strategy, and clinical operations. You can defer your operational investments.

article thumbnail

Tocilizumab biosimilar by Bio-Thera Solutions for Rheumatoid Arthritis: Likelihood of Approval

Pharmaceutical Technology

Tocilizumab biosimilar is under clinical development by Bio-Thera Solutions and currently in Pre-Registration for Rheumatoid Arthritis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Qinecsa Solutions acquires Insife to strengthen pharmacovigilance technology

Outsourcing Pharma

Qinecsa Solutions (Qinecsa), a lead company in technology-driven end-to-end pharmacovigilance solutions has announced its acquisition of Insife ApS (Insife), a Danish-based firm specializing in innovative pharmacovigilance platforms.

article thumbnail

Botanical Solutions Inc: Transforming vaccine adjuvant production with tree bark

BioPharma Reporter

During DCAT this year, Gaston Saperi from Botanical Solutions Inc., BSI, sat down with Liza Laws, the senior editor of OSP and BPR to discuss his companyâs pioneering work in revolutionizing vaccine adjuvant production.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies.

article thumbnail

Diversity, Equity, and Inclusion Data Service for clinical development 

Drug Discovery World

It’s great to see companies like Phesi and Krystelis delivering practical solutions and services to help companies meet these new regulations quickly and effectively. Without diverse patient cohorts that accurately reflect the patient population a drug is intended for, we cannot ensure that drugs will be fully safe or effective.

article thumbnail

Rare Disease Day: Emmes Endpoints Solutions submits Duchenne video assessment qualification plan to FDA

Outsourcing Pharma

In a seminal move coinciding with Rare Disease Day, Emmes Endpoints Solutions has taken a significant step forward in the realm of rare disease research.